Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy-Reference-Cited by-同舟云学术

Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy

Published:2011-03 Issue:3 Volume:161 Page:487-493
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Trachtenberg Barry,Velazquez Darcy L.,Williams Adam R.,McNiece Ian,Fishman Joel,Nguyen Kim,Rouy Didier,Altman Peter,Schwarz Richard,Mendizabal Adam,Oskouei Behzad,Byrnes John,Soto Victor,Tracy Melissa,Zambrano Juan Pablo,Heldman Alan W.,Hare Joshua M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step;Boyle;Circulation,2006

2. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity;Quevedo;Proc Natl Acad Sci U S A,2009

3. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation;Hatzistergos;Circ Res,2010

4. Intracoronary bone marrow–derived progenitor cells in acute myocardial infarction;Schachinger;N Engl J Med,2006

5. Autologous bone marrow–derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial;Janssens;Lancet,2006

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research hotspots and emerging trends of mesenchymal stem cells in cardiovascular diseases: a bibliometric-based visual analysis;Frontiers in Cardiovascular Medicine;2024-05-30

2. Adipose mesenchymal stem cell-derived soluble factors, produced under hypoxic condition, efficiently support in vivo angiogenesis;Cell Death Discovery;2023-05-23

3. Mitochondrial Transfer in Cardiovascular Disease: From Mechanisms to Therapeutic Implications;Frontiers in Cardiovascular Medicine;2021-11-26

4. An overview of mesenchymal stem cells and their potential therapeutic benefits in cancer therapy (Review);Oncology Letters;2021-09-14

5. Surfing the clinical trials of mesenchymal stem cell therapy in ischemic cardiomyopathy;Stem Cell Research & Therapy;2021-06-23